Translational models for vascular cognitive impairment: A review including larger species

  • Atticus H. Hainsworth*
  • , Stuart M. Allan
  • , Johannes Boltze
  • , Catriona Cunningham
  • , Chad Farris
  • , Elizabeth Head
  • , Masafumi Ihara
  • , Jeremy D. Isaacs
  • , Raj N. Kalaria
  • , Saskia A.M.J. Lesnik Oberstein
  • , Mark B. Moss
  • , Björn Nitzsche
  • , Gary A. Rosenberg
  • , Julie W. Rutten
  • , Melita Salkovic-Petrisic
  • , Aron M. Troen
  • *Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

91 Scopus citations

Abstract

Disease models are useful for prospective studies of pathology, identification of molecular and cellular mechanisms, pre-clinical testing of interventions, and validation of clinical biomarkers. Here, we review animal models relevant to vascular cognitive impairment (VCI). A synopsis of each model was initially presented by expert practitioners. Synopses were refined by the authors, and subsequently by the scientific committee of a recent conference (International Conference on Vascular Dementia 2015). Only peer-reviewed sources were cited. Methods: We included models that mimic VCI-related brain lesions (white matter hypoperfusion injury, focal ischaemia, cerebral amyloid angiopathy) or reproduce VCI risk factors (old age, hypertension, hyperhomocysteinemia, high-salt/high-fat diet) or reproduce genetic causes of VCI (CADASIL-causing Notch3 mutations). Conclusions: We concluded that (1) translational models may reflect a VCI-relevant pathological process, while not fully replicating a human disease spectrum; (2) rodent models of VCI are limited by paucity of white matter; and (3) further translational models, and improved cognitive testing instruments, are required.

Original languageEnglish
Article number16
JournalBMC Medicine
Volume15
Issue number1
DOIs
StatePublished - 25 Jan 2017

Bibliographical note

Funding Information:
AHH gratefully acknowledges funding from Alzheimer’s Drug Discovery Foundation (ADDF grant no. 20140901), Alzheimer’s Society UK (PG146/151) and Alzheimer’s Research UK (PPG2014A-8). SMA received research funding from the British Heart Foundation and EPSRC (UK). CC is funded by the MRC (UK) Centre for Doctoral Training in Regenerative Medicine (grant no. EP/L014904/1). AMT was supported in this work by Israel Science Foundation (ISF) Grant 1353/11.

Publisher Copyright:
© 2017 The Author(s).

Keywords

  • Experimental models
  • In vivo models
  • Translational models
  • VCID
  • Vascular cognitive impairment
  • Vascular dementia

Fingerprint

Dive into the research topics of 'Translational models for vascular cognitive impairment: A review including larger species'. Together they form a unique fingerprint.

Cite this